Renal Tubular Acidosis (RTA) - Complete NEET PG Guide

Definition

• Normal anion gap (no retention of phosphate, sulfate)
• GFR is normal or only mildly reduced
• Inappropriately high urine pH for the degree of systemic acidosis

Normal Renal Acid-Base Physiology (Quick Review)

Classification of RTA

TYPE 1 RTA - Distal RTA (Most Common, Most Important for NEET PG)

Mechanism

• Failure of alpha-intercalated cells to secrete H+ into the collecting duct
• Subtypes:
  • Proton secretion defect (most common) - H+-ATPase mutation or damage
  • Back-leak defect - H+ secreted but leaks back through damaged apical membrane (classic with amphotericin B)
  • Voltage-dependent (hyperkalemic) - reduced ENaC activity impairs both H+ and K+ secretion

Key Features

• Hypokalemia + hyperchloremic NAGMA
• Urine pH persistently >5.5 even in systemic acidosis (hallmark)
• Nephrocalcinosis and nephrolithiasis (calcium phosphate/oxalate stones) in up to 70% - caused by:
  • Hypercalciuria (bone buffering releases calcium)
  • Hypocitraturia (citrate reabsorption increased due to intracellular acidosis)
  • Alkaline urine favors calcium phosphate precipitation
• Bone disease (osteomalacia, rickets in children)
• Urine anion gap (UAG) = positive (Na+ + K+ - Cl- is positive, indicating low NH4+)

Causes

• ATP6V1B1 mutations (H+-ATPase B1 subunit) - autosomal recessive with sensorineural deafness
• SLC4A1 mutations (anion exchanger AE1, Cl-/HCO3-) - autosomal dominant or recessive
• Medullary sponge kidney

• Autoimmune: Sjögren syndrome (most common cause in adults), SLE, rheumatoid arthritis, primary biliary cirrhosis
• Drugs: Amphotericin B (back-leak), lithium, ifosfamide, topiramate, acetazolamide
• Hypergammaglobulinemia

Key Points for NEET PG

• Most common cause of RTA associated with stone formation
• Classic association: Sjögren syndrome + distal RTA
• Amphotericin B = classic drug causing type 1 RTA (back-leak mechanism)
• Bone disease is common; nephrocalcinosis is a hallmark
• Hypokalemia worsens with treatment (alkali increases distal K+ loss)

Treatment

• Oral NaHCO3 or potassium citrate (preferred - also corrects hypokalemia and hypocitraturia)
• Modest doses ~1-3 mEq/kg/day
• Potassium supplementation required

TYPE 2 RTA - Proximal RTA

Mechanism

• Reduced bicarbonate reabsorption in the proximal tubule (threshold lowered from normal 22 mmol/L to ~15 mmol/L)
• Once plasma HCO3- falls below the new threshold, what's filtered is fully reabsorbed and urine acidifies normally
• Isolated proximal RTA is rare; most often occurs as part of Fanconi syndrome

Fanconi Syndrome

• HCO3- (RTA)
• Glucose (glycosuria with normal plasma glucose)
• Amino acids (aminoaciduria)
• Phosphate (hypophosphatemia, rickets)
• Uric acid (hypouricemia)
• Low-molecular-weight proteins
• Potassium, sodium

Key Features

• Hypokalemia + NAGMA
• Urine pH < 5.5 at baseline (distal acidification intact), but > 5.5 after alkali therapy (HCO3- spills into distal tubule)
• Fractional excretion of HCO3- > 10-15% when serum HCO3- > 20 mmol/L (diagnostic)
• Nephrocalcinosis is rare (unlike type 1)
• Metabolic bone disease (hypophosphatemia driven rickets/osteomalacia) is common

Causes

• Genetic: Cystinosis (most common in children), Wilson disease, tyrosinemia, galactosemia, hereditary fructose intolerance, Lowe syndrome
• Drugs: Tenofovir (HIV treatment), ifosfamide, cidofovir, adefovir, aristolochic acid, heavy metals (lead, mercury, cadmium)
• Multiple myeloma (light chain deposits)
• Sjögren syndrome, renal transplant rejection

Key Points for NEET PG

• Cystinosis is the most common cause in children
• Multiple myeloma is a key cause in adults
• Tenofovir (nucleoside reverse transcriptase inhibitor) = important drug cause
• Paradox: Alkali treatment worsens hypokalemia (enhanced HCO3- delivery to distal nephron increases K+ secretion)
• High doses of NaHCO3 required (up to 10-15 mEq/kg/day in children) + K+ supplementation

Treatment

• High-dose oral NaHCO3 or K-citrate (requires large amounts because HCO3- is rapidly lost in urine)
• Treat underlying cause
• Phosphate supplementation + vitamin D for rickets

TYPE 4 RTA - Hyperkalemic RTA (Most Common Type Overall)

Mechanism

• Aldosterone deficiency or resistance → failure of distal K+ and H+ secretion
• Aldosterone normally promotes Na+ reabsorption (via ENaC), creating a lumen-negative potential that drives both K+ and H+ secretion
• Without aldosterone effect: Hyperkalemia + mild metabolic acidosis
• Hyperkalemia itself impairs renal ammonia synthesis, further worsening acid excretion

Key Features

• Hyperkalemia (hallmark, distinguishes from types 1 and 2)
• Mild NAGMA (HCO3- usually 15-20 mEq/L, less severe than types 1/2)
• Urine pH < 5.5 (distal H+-ATPase intact, but NH4+ excretion low due to hyperkalemia)
• Urine AG positive
• Most common in diabetic nephropathy (hyporeninemic hypoaldosteronism)

Causes

• Hyporeninemic hypoaldosteronism (most common) - diabetic nephropathy, tubulointerstitial disease, NSAIDs, chronic urinary obstruction
• Adrenal insufficiency (Addison's disease)
• Heparin (inhibits aldosterone synthesis)

• PHA Type I (autosomal dominant - mineralocorticoid receptor mutation; autosomal recessive - ENaC mutation)
• PHA Type II / Gordon syndrome (WNK kinase mutations)

• Spironolactone, eplerenone (aldosterone antagonists)
• Amiloride, triamterene (ENaC blockers)
• ACE inhibitors, ARBs
• Trimethoprim (blocks ENaC)
• Calcineurin inhibitors (cyclosporine, tacrolimus)

Key Points for NEET PG

• Most common cause: Diabetic nephropathy (hyporeninemic hypoaldosteronism)
• Urine pH is usually < 5.5 (acid urine - intact H+-ATPase, just reduced NH4+ buffer)
• This is the most common type of RTA overall
• Mild acidosis compared to types 1 and 2

Treatment

• Treat underlying cause
• Fludrocortisone if true aldosterone deficiency
• Loop diuretics (furosemide) to promote K+ excretion and stimulate aldosterone
• Low potassium diet, cation exchange resins
• Avoid drugs that worsen hyperkalemia

TYPE 3 RTA (Rare - Know for Completion)

• Mixed proximal + distal defect
• Caused by carbonic anhydrase II (CA II) deficiency (recessive mutation)
• Triad: Osteopetrosis + cerebral calcification + mental retardation
• "Type 3" label is sometimes abandoned; considered a variant

Urine Anion Gap (UAG) - Key Diagnostic Tool

• Positive UAG → low urine NH4+ → renal tubular cause of acidosis (all types of RTA)
• Negative UAG → high urine NH4+ → extrarenal cause (e.g., diarrhea)

Summary Comparison Table (High-Yield NEET PG)

High-Yield NEET PG One-Liners

1. Type 1 RTA = distal, hypokalemia, urine pH always >5.5, nephrocalcinosis, Sjögren syndrome
2. Amphotericin B = type 1 RTA (back-leak proton gradient defect)
3. Type 2 RTA = proximal, Fanconi syndrome, urine pH <5.5 at baseline but >5.5 with treatment
4. Cystinosis = most common genetic cause of Fanconi syndrome/type 2 RTA in children
5. Tenofovir = type 2 RTA / Fanconi syndrome (used in HIV treatment)
6. Type 4 RTA = hyperkalemic, urine pH <5.5, most common cause = diabetic nephropathy (hyporeninemia)
7. UAG positive = RTA; UAG negative = diarrhea (extrarenal HCO3- loss)
8. Type 3 RTA = carbonic anhydrase II deficiency, osteopetrosis + cerebral calcification
9. Nephrocalcinosis: Type 1 > never in type 2 or 4
10. Alkali therapy worsens hypokalemia in Type 2 RTA (increased K+ wasting in distal tubule)
11. Gordon syndrome (PHA II) = type 4 RTA due to WNK kinase mutations - hyperkalemia, hypertension

Normal Renal Physiology - The Nephron (Simplest Words)

What is a Nephron?

The Big Picture: What a Nephron Does

1. Filtration - push fluid out of blood into the tubule
2. Reabsorption - take back the good stuff from tubule into blood
3. Secretion - dump extra waste from blood into tubule

Parts of the Nephron - One by One (Simple)

BLOOD → Glomerulus → Bowman's Capsule → Proximal Tubule 
      → Loop of Henle → Distal Convoluted Tubule 
      → Collecting Duct → URINE

1. GLOMERULUS + BOWMAN'S CAPSULE (The Filter)

• The glomerulus is a ball of tiny blood vessels (capillaries)
• Blood is pushed under pressure through these capillaries
• Water, salts, glucose, urea, amino acids - everything small - gets squeezed out into Bowman's capsule
• Big things stay in blood: red blood cells, proteins, platelets
• What enters the tubule = glomerular filtrate (~180 L/day!)
• Normal GFR = 125 mL/min (90-120 in women)

Think of it like a coffee filter - water and small particles pass through, big chunks stay behind.

2. PROXIMAL CONVOLUTED TUBULE - PCT (The Workhorse)

• Reabsorbs 60-70% of the filtrate - the bulk of the work
• Has a brush border (lots of tiny finger-like projections = microvilli) to increase surface area
• What gets reabsorbed here:
  • All glucose (via SGLT2 cotransporter)
  • All amino acids
  • ~85-90% of HCO3- (bicarbonate - via NHE3 exchanger + carbonic anhydrase)
  • ~67% of Na+, water, Cl- (water follows sodium passively via aquaporin-1)
  • Phosphate (regulated by PTH - PTH inhibits reabsorption)
  • Uric acid
• Also secretes organic acids, drugs (penicillin, methotrexate), creatinine

The PCT is the "bulk recovery" station - it grabs back almost everything useful before the filtrate moves on.

• NHE3 (apical) - Na+ in, H+ out (drives HCO3- reabsorption)
• Na+/K+-ATPase (basolateral) - the master pump that keeps everything moving
• NBC-1 (basolateral) - moves HCO3- back into blood

3. LOOP OF HENLE (The Concentrating Machine)

Thin Descending Limb

• Permeable to water (aquaporin-1), NOT to salt
• Water is sucked out into the salty medulla
• Filtrate becomes concentrated (more salty) as it goes down

Thin Ascending Limb

• Permeable to salt (NaCl diffuses out passively), NOT to water
• Filtrate starts to dilute

Thick Ascending Limb (TAL)

• Impermeable to water - this is the key!
• Actively pumps Na+, K+, 2Cl- out using NKCC2 (the target of furosemide/loop diuretics)
• K+ is recycled back into lumen via ROMK channel
• Creates a very salty medulla (600-1200 mOsm) = the concentration gradient
• Since salt leaves but water can't, the filtrate becomes dilute in the TAL

Think of the Loop of Henle like a salt pump that makes the surrounding tissue very salty. This saltiness is used later to pull water out of urine and concentrate it.

4. DISTAL CONVOLUTED TUBULE - DCT (Fine Tuning)

• Very short segment (10-12 mm)
• Impermeable to water → more dilution occurs
• Main transporter: NCC (Na+/Cl- cotransporter) - target of thiazide diuretics
• Fine-tunes Na+, Ca2+, Mg2+
• PTH acts here to increase Ca2+ reabsorption (via TRPV5 channel)
• Aldosterone starts acting here (ENaC channels appear in late DCT)

DCT = the "fine adjustment" dial for Na+ and Ca2+.

5. COLLECTING DUCT (Final Decision Maker)

Principal Cells (Na+ and Water)

• Under aldosterone → opens ENaC (sodium channel) on luminal side
  • Na+ enters → creates a negative charge in the lumen
  • This negative charge pulls K+ out via ROMK channel (potassium secretion)
• Under ADH (vasopressin) → inserts aquaporin-2 into the luminal membrane
  • Water is reabsorbed along concentration gradient
  • Without ADH → water stays in tubule → dilute urine (as in diabetes insipidus)

Alpha-Intercalated Cells (Acid-Base)

• Secrete H+ via H+-ATPase (luminal side)
• Reabsorb HCO3- via Cl-/HCO3- exchanger (basolateral)
• Makes the urine acidic - can lower urine pH to 4.5

Beta-Intercalated Cells (Alkalosis correction)

• Do the opposite: secrete HCO3- into lumen (via pendrin)
• Used when blood is too alkalotic

The collecting duct is the final filter - controlled by hormones (ADH and aldosterone) to produce the exact urine volume and composition the body needs.

Summary Table - Each Segment at a Glance

Key Hormones and Their Targets

The Final Numbers (Important for Exams)

• Blood filtered per day: ~180 L
• Urine produced per day: ~1.5 L
• So 99% is reabsorbed!
• Normal GFR: 125 mL/min (90-120 in women)
• Renal plasma flow: 650 mL/min
• Filtration fraction = GFR/RPF = 125/650 = ~0.2 (20%)

One-Line Memory Tricks

• PCT = "Please Come Take" glucose, amino acids, bicarb (everything useful)
• Descending loop = "Water leaves" (permeable to water)
• Ascending loop (TAL) = "Salt leaves, water stays" (NKCC2, impermeable to water)
• DCT = "Dial" (fine-tunes Ca, Na)
• Collecting duct = "Final boss" (ADH + Aldosterone control)
• Furosemide = blocks NKCC2 in TAL
• Thiazides = block NCC in DCT
• Spironolactone/Amiloride = block collecting duct (aldosterone pathway)

NEET PG MCQs - Renal Tubular Acidosis & Nephron Physiology

SECTION A: RENAL TUBULAR ACIDOSIS

• A) Sjögren syndrome
• B) Diabetes mellitus
• C) Multiple myeloma
• D) Cystinosis

Type 1 (distal) RTA - urine pH always >5.5 + hypokalemia + nephrolithiasis. Most common acquired cause in adults = Sjögren syndrome. Diabetes → Type 4 RTA. Multiple myeloma → Type 2 RTA. Cystinosis → Type 2 RTA in children.

• A) Decreased HCO3- reabsorption in PCT
• B) Back-leak of H+ through damaged apical membrane
• C) Aldosterone deficiency
• D) Reduced H+/K+-ATPase synthesis

Amphotericin B increases membrane permeability in the collecting duct → secreted H+ leaks back into the cell → cannot maintain H+ gradient → Type 1 RTA (back-leak subtype).

• A) Type 2
• B) Type 4
• C) Type 1
• D) Type 3

Distal RTA causes alkaline urine + hypercalciuria + hypocitraturia → ideal conditions for calcium phosphate stone/nephrocalcinosis formation. Type 2 and 4 rarely cause stones.

• A) Type 1 RTA
• B) Fanconi syndrome (Type 2 RTA)
• C) Type 4 RTA
• D) Bartter syndrome

Fanconi syndrome = generalized PCT dysfunction → loses glucose, amino acids, phosphate, uric acid, HCO3-. Classic presentation: rickets + glycosuria with normal blood glucose.

• A) Type 1
• B) Type 2
• C) Type 3
• D) Type 4

Tenofovir causes Fanconi syndrome/Type 2 (proximal) RTA. Other drugs: ifosfamide, cidofovir, aristolochic acid.

• A) Type 1 RTA
• B) Type 2 RTA
• C) Type 4 RTA
• D) Diarrhea-induced acidosis

Type 4 RTA = hyperkalemia + mild NAGMA + urine pH <5.5 (H+-ATPase intact but NH4+ low due to hyperkalemia). Most common cause = diabetic nephropathy (hyporeninemic hypoaldosteronism). ACE inhibitor worsens it.

• A) Raises serum K+ further
• B) Worsens hypokalemia
• C) Normalizes urine pH permanently
• D) Reduces nephrocalcinosis

NaHCO3 delivers more HCO3- to the distal tubule → increased K+ secretion → worsening hypokalemia. That is why K+ supplementation is always co-administered.

• A) Serum (Na+ + K+) - Serum Cl-
• B) Urine Na+ - Urine Cl-
• C) Urine (Na+ + K+) - Urine Cl-
• D) Urine Na+ + Urine K+ + Urine Cl-

A positive UAG = low urine NH4+ = renal cause (RTA). A negative UAG = high urine NH4+ = extrarenal cause (diarrhea). NH4+ is excreted with Cl-, so high NH4+ → high Cl- → UAG becomes negative.

• A) Deafness + rickets + nephrocalcinosis
• B) Osteopetrosis + cerebral calcification + mental retardation
• C) Polyuria + polydipsia + hyperkalemia
• D) Glycosuria + aminoaciduria + hyperphosphatemia

Type 3 RTA = Carbonic anhydrase II (CA-II) deficiency. CA-II is needed in both PCT and DCT + osteoclasts + brain. Deficiency → mixed RTA + osteopetrosis (osteoclasts fail to resorb bone) + cerebral calcification.

• A) Amphotericin B
• B) Acetazolamide
• C) Topiramate
• D) Lithium

Topiramate and acetazolamide inhibit carbonic anhydrase → reduce H+ generation → Type 1 (and Type 2) RTA. Amphotericin B → back-leak. Lithium → nephrogenic DI but can also cause Type 1 RTA by damaging collecting duct cells.

SECTION B: NEPHRON PHYSIOLOGY

• A) 90 mL/min
• B) 125 mL/min
• C) 180 mL/min
• D) 650 mL/min

GFR = 125 mL/min. Total filtrate/day = 180 L. Renal plasma flow = 650 mL/min. Filtration fraction = GFR/RPF = 125/650 = ~20%.

• A) NHE3 in PCT
• B) NCC in DCT
• C) NKCC2 in thick ascending limb
• D) ENaC in collecting duct

NKCC2 = Na-K-2Cl cotransporter in TAL. Furosemide blocks it → no salt reabsorption → no concentration gradient → dilute urine + loss of Na, K, Cl. TAL is also impermeable to water → this is where dilution happens.

• A) Thin descending limb
• B) Proximal convoluted tubule
• C) Thick ascending limb of loop of Henle
• D) Collecting duct

TAL is called the diluting segment - salt leaves, water cannot → filtrate becomes dilute, medulla becomes hypertonic. This gradient is what allows ADH to concentrate urine in the collecting duct.

• A) Aquaporin-1
• B) Aquaporin-2
• C) Aquaporin-4
• D) ROMK

ADH → V2 receptor → cAMP → AQP-2 vesicles inserted into luminal membrane → water reabsorption. AQP-1 is always present in PCT and descending loop (not regulated). Absence of AQP-2 = Nephrogenic Diabetes Insipidus.

• A) NKCC2 in TAL
• B) NCC in DCT
• C) ENaC in collecting duct
• D) NHE3 in PCT

NCC = Na-Cl cotransporter in the Distal Convoluted Tubule. Thiazides block NCC → Na+ and water loss. Paradoxically used in nephrogenic DI because they cause mild volume depletion → enhanced PCT reabsorption → less water to collecting duct → less polyuria.

• A) Increase phosphate reabsorption
• B) Decrease phosphate reabsorption
• C) Increase glucose reabsorption
• D) Decrease calcium reabsorption

PTH inhibits Na+/phosphate cotransporter in PCT → phosphaturia → lowers serum phosphate. PTH simultaneously increases Ca2+ reabsorption in DCT. In hyperparathyroidism: ↓ phosphate + ↑ Ca2+.

• A) ADH
• B) Aldosterone
• C) PTH
• D) ANP

Aldosterone → opens ENaC (Na+ enters) → lumen becomes negative → K+ exits via ROMK → K+ secretion. Also promotes H+ secretion from alpha-intercalated cells. Loss of aldosterone → hyperkalemia + metabolic acidosis (Type 4 RTA).

• A) Glomerulus
• B) Proximal convoluted tubule
• C) Loop of Henle
• D) Collecting duct

This is the classic description of Fanconi syndrome - all the substrates normally reabsorbed 100% in the PCT are lost. Glomerular disease → proteinuria (large proteins), not these findings.

• A) Where PCT meets the loop of Henle
• B) Where the thick ascending limb returns to its own glomerulus
• C) Where the collecting duct opens into the renal pelvis
• D) At the tip of the loop of Henle

Macula densa = specialized cells at the end of TAL that lie adjacent to the afferent arteriole of the same nephron's glomerulus. They sense NaCl concentration in tubular fluid and regulate GFR via tubuloglomerular feedback (TGF). Also stimulate renin secretion when NaCl is low.

• A) Gitelman syndrome
• B) Bartter syndrome
• C) Liddle syndrome
• D) Gordon syndrome

Bartter syndrome = genetic defect in TAL transporters (NKCC2, ROMK, ClC-Kb, Barttin) → mimics chronic furosemide use → hypokalemia + metabolic alkalosis + hypercalciuria + normal/low BP. Gitelman = DCT defect (NCC mutation) → hypokalemia + alkalosis + hypomagnesemia + hypocalciuria. Liddle = gain of function ENaC → hypertension + hypokalemia.

Quick Exam Cheat Sheet

RTA - Built From Zero, Step by Step

STEP 1: Understand the ONE Problem in RTA

1. Throwing acid (H+) out into urine
2. Keeping alkali (HCO3-) in the blood

One sentence: RTA = kidney tubules can't handle acid properly, so blood becomes acidic even though the kidney is otherwise working fine.

STEP 2: The Simple Analogy

BLOOD → [Filter] → [Section A: PCT] → [Section B: Loop] → [Section C: DCT/Collecting duct] → URINE

• Section A workers (PCT) job = collect all the good alkali (HCO3-) and send it back to blood
• Section C workers (Collecting duct) job = dump acid (H+) into the urine drain

STEP 3: Now Understand Each Type as a Story

🔴 TYPE 1 RTA - "The Acid Dumper is Broken"

• H+ cannot be dumped into urine
• H+ builds up in blood → blood becomes acidic
• Urine NEVER becomes acidic → urine pH stays >5.5 always (this is the hallmark)

The toilet flush is broken. No matter how much waste there is, nothing gets flushed. The waste (acid) stays in the house (blood).

• Normally, when H+ is pumped OUT into urine, K+ stays IN
• When H+ pump is broken, the body still tries to maintain electrochemical balance → K+ gets thrown out instead
• Result: Hypokalemia

• Acidic blood → body borrows calcium from bones to neutralize acid → hypercalciuria
• Less citrate in urine (citrate is used up to buffer acid in cells) → hypocitraturia
• Alkaline urine + excess calcium + no citrate (citrate normally prevents stones) = STONES + NEPHROCALCINOSIS

🟡 TYPE 2 RTA - "The HCO3- Collector is Broken"

• HCO3- leaks into urine instead of going back to blood
• Blood loses alkali → blood becomes acidic

• BUT if you give alkali treatment (NaHCO3), so much HCO3- floods the tubule that even the collecting duct can't handle it → urine pH goes >5.5

The bucket has a hole at the top (PCT). Water (HCO3-) keeps leaking before it reaches the tap. But the tap itself (collecting duct) works fine.

• The PCT does EVERYTHING - glucose, amino acids, phosphate, HCO3- reabsorption
• If PCT workers go on strike (Fanconi), ALL of these are lost → glycosuria + aminoaciduria + phosphaturia + RTA

• Normally: mild hypokalemia (aldosterone goes up to compensate Na+ loss)
• With alkali treatment: K+ drops dramatically - extra HCO3- reaching distal tubule pulls K+ out with it

🟢 TYPE 4 RTA - "The Manager is Missing"

1. Absorb Na+
2. Secrete K+
3. Secrete H+

• K+ stays in blood → Hyperkalemia
• H+ stays in blood → mild metabolic acidosis
• The workers (pumps) are physically fine but have no instructions

• The H+-ATPase pump is NOT broken - just under-stimulated
• So urine CAN be acidified → urine pH <5.5
• BUT the total amount of H+ excreted is low because hyperkalemia blocks ammonia (NH3) production - NH3 is the buffer that carries H+ out as NH4+
• Less buffer = less H+ can be excreted = acidosis

The factory (collecting duct) is functional, but the manager (aldosterone) didn't show up. Workers are sitting idle. A little work happens (urine acidifies), but not enough to clear all the acid.

STEP 4: The ONE KEY DIFFERENCE Chart

                TYPE 1          TYPE 2          TYPE 4
Problem:        Distal pump     Proximal        Aldosterone
                broken          leaking         missing

K+:             LOW ↓           LOW ↓           HIGH ↑

Urine pH:       ALWAYS >5.5     <5.5 baseline   <5.5
                                >5.5 with Rx

Stones?:        YES ✓           NO ✗            NO ✗

Fanconi?:       NO ✗            YES ✓           NO ✗

STEP 5: The Urine pH Trick (Most Confusing Part - Simplified)

"Why is urine pH high in Type 1 but LOW in Type 4, even though both are RTAs?"

• Type 1: The H+ pump (H+-ATPase) is physically broken → can't push H+ into urine → urine stays alkaline (>5.5)
• Type 4: The H+ pump is fine, but the body has no buffer (NH3) to carry H+ out because hyperkalemia blocks ammonia production. So a little H+ goes in → urine is mildly acidic (<5.5) - but NOT ENOUGH to clear all the acid load from blood.

• Type 1 = pump broken → zero acid in urine → pH high
• Type 4 = pump works but bucket (NH3 buffer) is missing → little acid in urine → pH low, but still not enough

STEP 6: Drug Causes - Logic Based

STEP 7: Causes - One Word Association

• Sjögren syndrome (most common adult cause)
• Amphotericin B
• SLE, rheumatoid arthritis
• Hereditary (H+-ATPase gene mutations)

• Cystinosis (children - #1 genetic cause)
• Multiple myeloma (adults)
• Tenofovir, ifosfamide
• Wilson disease, galactosemia, fructose intolerance

• Diabetic nephropathy (#1 cause)
• Addison's disease
• ACE inhibitors, ARBs, heparin, trimethoprim, spironolactone

STEP 8: The Final Anchor - One Story Per Type

FINAL SUMMARY IN 3 LINES EACH

How K+ Links to HCO3- and NH3

First: Understand What the Kidney Is Trying to Do

Remove excess H+ (acid) from the body through urine

1. Keep HCO3- (alkali) - don't let it spill into urine
2. Excrete H+ as NH4+ (using NH3 as a carrier)

PART 1: K+ and HCO3- Relationship

The Basic Rule:

K+ and H+ compete to move in and out of cells

When K+ is LOW (Hypokalemia):

Blood K+ is low → body needs to get K+ from somewhere
→ K+ moves OUT of cells into blood
→ To maintain electrical neutrality inside the cell,
  H+ moves IN to the cell (to replace K+)
→ Blood loses H+ → Blood becomes ALKALINE
→ But inside the KIDNEY tubule cells, H+ is now HIGH
→ More H+ inside tubule cells = more H+ pumped into urine
→ More HCO3- regenerated and sent to blood
→ Blood HCO3- goes UP

• Blood = alkalosis (high pH, high HCO3-)
• Urine = paradoxically acidic (more H+ being pumped out)
• This is called "paradoxical aciduria" - seen in hypokalemic alkalosis (e.g., vomiting)

When K+ is HIGH (Hyperkalemia):

Blood K+ is high → K+ moves INTO cells
→ To maintain electrical neutrality,
  H+ moves OUT of cells into blood
→ Blood gains H+ → Blood becomes ACIDIC
→ Inside kidney tubule cells, H+ is now LOW
→ Less H+ available to pump into urine
→ Less HCO3- regenerated
→ Blood HCO3- goes DOWN

• Blood = acidosis (low pH, low HCO3-)
• This is exactly what happens in Type 4 RTA

Simple Visual:

        CELL                    BLOOD

High K+ in blood:
K+ ────────────→  enters cell
H+ ←────────────  exits cell      → Blood becomes ACID
                                   HCO3- falls

Low K+ in blood:
K+ ←────────────  exits cell
H+ ────────────→  enters cell     → Blood becomes ALKALINE
                                   HCO3- rises

One line rule: K+ and H+ always move in OPPOSITE directions across cell membranes.

PART 2: K+ and NH3 Relationship

First, What is NH3 and Why Does It Matter?

NH3 + H+ → NH4+  (ammonium)

Where Does NH3 Come From?

Glutamine  →  (enzyme: glutaminase)
           →  NH3 + HCO3-  (both produced together)

• NH3 → goes into tubule lumen → picks up H+ → becomes NH4+ → excreted
• HCO3- → goes into blood → helps correct acidosis

Now: How Does High K+ Kill This System?

High K+ in blood
→ K+ enters cells (including PCT cells)
→ H+ exits cells into blood (K+/H+ exchange)
→ Inside PCT cells: H+ is now LOW
→ Low intracellular H+ = ALKALINE inside the cell
→ Alkaline environment SUPPRESSES glutaminase enzyme
→ Less glutamine is broken down
→ Less NH3 produced
→ Less NH4+ excreted in urine
→ Less H+ removed from body
→ Acidosis worsens

Low K+ in blood
→ K+ exits cells
→ H+ enters cells (PCT becomes acidic inside)
→ Acidic intracellular environment STIMULATES glutaminase
→ More NH3 produced
→ More H+ excreted as NH4+
→ Acidosis corrected

Simple Visual:

HIGH K+  →  cell interior becomes ALKALINE
         →  glutaminase SUPPRESSED
         →  less NH3
         →  less H+ excreted
         →  MORE ACIDOSIS  ← despite urine pH being <5.5

LOW K+   →  cell interior becomes ACIDIC
         →  glutaminase STIMULATED
         →  more NH3
         →  more H+ excreted
         →  CORRECTS ACIDOSIS

PART 3: Tying It All Together - Why Type 4 RTA Makes Sense Now

Diabetic nephropathy
→ Less RENIN
→ Less Angiotensin
→ Less ALDOSTERONE
→ Collecting duct: less Na+ absorption, less K+ secretion
→ K+ stays in blood = HYPERKALEMIA

Now two things happen simultaneously:

① K+ HIGH → H+ exits cells → blood acidosis (↓HCO3-)

② K+ HIGH → PCT cells become alkaline
           → glutaminase suppressed
           → less NH3 made
           → less NH4+ in urine
           → less H+ excreted

Both effects together → METABOLIC ACIDOSIS

• The H+-ATPase pump in collecting duct is physically working
• It pumps whatever little H+ there is into urine
• But there's not enough NH3 buffer to carry the acid load
• So urine is "acidic" but total acid excretion is insufficient

Analogy: The toilet flushes normally (pH <5.5), but the sewer pipe is tiny (no NH3 buffer). You can flush small amounts, but a big load (normal acid production) won't clear.

PART 4: Why Hypokalemia in Type 1 and Type 2 RTA?

Type 1 RTA + Hypokalemia:

• H+ pump in collecting duct is broken → H+ cannot go into urine
• The lumen needs to be electrically balanced
• To maintain luminal negativity, K+ is secreted instead (via ROMK)
• H+ and K+ compete for secretion → less H+ secretion = more K+ secretion → K+ loss

• Acidosis triggers aldosterone release
• Aldosterone increases K+ secretion in collecting duct → more K+ lost in urine

H+ pump broken → K+ secreted in its place → Hypokalemia

Type 2 RTA + Hypokalemia (and why alkali worsens it):

• PCT leaks HCO3- → Na+ follows (because Na+ is linked to HCO3- transport)
• Na+ delivery to distal tubule increases
• Aldosterone responds → more Na+ reabsorbed, more K+ secreted → mild hypokalemia

• Even more HCO3- arrives at collecting duct
• HCO3- in the lumen creates a stronger negative charge
• This pulls K+ out MORE aggressively via ROMK
• K+ drops dramatically → this is why you MUST give K+ supplements with alkali in Type 2

FINAL SUMMARY TABLE

The 3 Rules to Remember Forever